Skip to main content

Scribe Therapeutics, Inc. (SCTX)

Sector
Healthcare
Industry
Biotechnology
Last price
$15.70
As of

Kresmion compiles this page from SCTX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.

Scribe Therapeutics, Inc. (SCTX): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-02.

As of . Source: SEC EDGAR filings for SCTX. Method and limitations.

COMPANY DOSSIER

See the full SCTX dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for SCTX on one page. Preview it with sample data, then open it live with a free account.

Preview the SCTX dossier

Active events for SCTX

  • mediumEarnings above estimates

    Q2-2026: Beat consensus by 13.6%, EPS $-2.62 vs $-3.032 estimate

FREE, NO ACCOUNT

Every event on SCTX, as it fires

New filings, 13F moves and cross asset events on SCTX land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

No non-option holdings from tracked managers in this reporting quarter.

Recent SEC filings, SCTX

More data on SCTX

Related tickers

Cite this data

Kresmion counts the managers it follows that reported a non-option position in SCTX on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on SCTX in the last 180 days.

Upstream: SEC EDGAR filings for SCTX

Kresmion, "Scribe Therapeutics, Inc. (SCTX) institutional holdings and SEC filings", data as of 2026-09-14, https://kresmion.com/research/SCTX. Upstream data: SEC EDGAR filings for SCTX.

Link to this data (HTML):

<a href="https://kresmion.com/research/SCTX">Scribe Therapeutics, Inc. (SCTX) institutional holdings and SEC filings (Kresmion)</a>

Writing about this? Press contact and ready-to-quote figures

Follow SCTX on a live board

Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to SCTX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.

Preview the SCTX dossier
Share

The SCTX intelligence card: the smart money composite, cross family confluence and the top current signal, with a link back to this page.